IBC Life Sciences, Wyndham Philadelphia at Franklin Plaza
June 2-3, 2005
With new regulatory and legislative initiatives, the pharmaceutical industry in entering an area of clinical research previously avoided due to the ethical, clinical and practical consideration that are involved when children are research subjects. Attend IBC’s Conducting Pediatric Trials conference to hear the latest on: ways the US and EU regulations will impact your clinical trial; how to determine the appropriate control group for a clinical trial; major issues in cancer drug development – design, formulations and market size; and using substudies to entice investigators to contribute to industry-sponsored trials with negligible cost. Plus, Philip D. Watson, M.D. of the University of Cincinnati will lead an interactive tutorial on Implementing Effective Recruitment and Retention Strategies for Pediatric Subjects.
|
|